The ADMIN-ICU survey: a survey on antimicrobial dosing and monitoring in ICUs | Zendy

Alexis Tabah | Zendy; Jan J. De Waele | Zendy; Jeffrey Lipman | Zendy; Jean Ralph Zahar | Zendy; Menino Osbert Cotta | Zendy; Greg Barton | Zendy; JeanFrançois Timsit | Zendy; Jason A. Roberts | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The ADMIN-ICU survey: a survey on antimicrobial dosing and monitoring in ICUs

Author(s) -

Alexis Tabah,

Jan J. De Waele,

Jeffrey Lipman,

Jean Ralph Zahar,

Menino Osbert Cotta,

Greg Barton,

JeanFrançois Timsit,

Jason A. Roberts

Publication year - 2015

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkv165

Subject(s) - medicine , meropenem , piperacillin , amikacin , colistin , vancomycin , dosing , intensive care , piperacillin/tazobactam , tazobactam , imipenem , gentamicin , therapeutic drug monitoring , intensive care medicine , emergency medicine , anesthesia , antimicrobial , antibiotics , pharmacokinetics , microbiology and biotechnology , antibiotic resistance , genetics , bacteria , pseudomonas aeruginosa , biology , staphylococcus aureus

There is little evidence and few guidelines to inform the most appropriate dosing and monitoring for antimicrobials in the ICU. We aimed to survey current practices around the world.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research